We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Events

26 Oct 2026 - 29 Oct 2026
16 Nov 2026 - 19 Nov 2026

Ingestible Micro-Robot Wirelessly Navigates Stomach for Remote Diagnosis of GI Tract

By HospiMedica International staff writers
Posted on 15 Jul 2024

Four out of five upper endoscopies typically result in negative outcomes, indicating no medical issues within the patient's stomach that require treatment. More...

Now, an ingestible micro-robot designed to wirelessly navigate the human stomach offers a breakthrough in gastrointestinal (GI) care.

Endiatx (Hayward, CA, USA) has launched PillBot, a revolutionary micro-robot designed to navigate the human stomach, offering a non-invasive, cost-effective alternative for GI diagnostics and treatment. Roughly the size of a vitamin pill, PillBot provides live video feedback as it moves through the water-filled stomach. After a patient ingests water and swallows the PillBot, a physician can remotely control the device using an internet-connected game controller to conduct a comprehensive scan of the stomach. This innovative approach reduces the need for more invasive procedures, lowers costs, and improves accessibility of GI diagnostic and treatment services. PillBot aims to spare many patients the discomfort associated with sedation and hospital visits, while also offering insurers a more economical option. Additionally, this device could help optimize hospital resources by identifying cases that require further investigation following an initial PillBot examination.

Endiatx plans to seek FDA clearance for PillBot following the completion of its clinical trials later this year, with a projected commercial launch in the U.S. by early 2026 and subsequent expansion into international markets, especially in developing countries where GI medical resources are scarce. The ongoing clinical trials have yielded promising results, demonstrating PillBot’s effectiveness and safety in practical applications. Going forward, Endiatx is exploring the integration of artificial intelligence (AI) technology into PillBot to enhance its diagnostic capabilities, potentially enabling routine screenings and acute care diagnostics. Such advancements could improve the early detection of conditions like stomach cancer, which is responsible for nearly 800,000 deaths worldwide annually. An AI-enhanced PillBot would autonomously navigate the stomach, analyze data, and deliver precise diagnostics, thus streamlining and improving the efficiency of GI care.

Related Links:
Endiatx


Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Hypodermic Syringe
SurTract™ Safety Syringe
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Half-matched bone marrow transplant expands access to curative treatment for children and young adults with severe aplastic anemia. (Photo courtes of Margarita Dionysiou using Bio Render)

Half-Matched Family Donors Could Expand Transplant Access for Severe Aplastic Anemia

Severe aplastic anemia is a rare, life-threatening disorder in which the bone marrow fails to produce enough healthy blood cells, leaving children and young adults vulnerable to anemia, infection, and bleeding.... Read more

Patient Care

view channel
Image: Researchers evaluated the Omni 128 cm long-axial field-of-view PET/CT system, which captures more of the body and radiotracer signal at once, potentially enabling shorter scans. (Photo courtesy of GE HealthCare)

Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging

Positron emission tomography/computed tomography (PET/CT) combines radiotracer-based functional imaging with anatomical detail to diagnose, stage, and monitor cancer. Conventional scanners image the body... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.